NewcelX Ltd.
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.96 | $0 | -$3M |
| 2025 Q4 | 1.29 | $0 | -$1,984 |
| 2025 Q2 | -10.50 | $0 | -$2M |
| 2024 Q4 | -26.30 | $0 | -$3M |
| 2024 Q2 | -1.94 | $0 | -$2M |
| 2023 Q4 | -1.40 | $0 | -$2,387 |
| 2023 Q2 |
| -2.00 |
| $0 |
| -$7M |
| 2022 Q4 | -2.90 | $0 | -$6M |